Aggarwal, R., Oddis, C. V., Goudeau, D., Koontz, D., Qi, Z., Reed, A. M., … Levesque, M. C. (2016). Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab. Rheumatology (Oxford), 55(9), 1710. https://doi.org/10.1093/rheumatology/kew275

Aggarwal, Rohit, Chester V. Oddis, Danielle Goudeau, Diane Koontz, Zengbiao Qi, Ann M. Reed, Dana P. Ascherman, and Marc C. Levesque. “Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.” Rheumatology (Oxford) 55, no. 9 (September 2016): 1710. https://doi.org/10.1093/rheumatology/kew275.

Aggarwal R, Oddis CV, Goudeau D, Koontz D, Qi Z, Reed AM, et al. Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab. Rheumatology (Oxford). 2016 Sep;55(9):1710.

Aggarwal, Rohit, et al. “Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab.” Rheumatology (Oxford), vol. 55, no. 9, Sept. 2016, p. 1710. Pubmed, doi:10.1093/rheumatology/kew275.

Aggarwal R, Oddis CV, Goudeau D, Koontz D, Qi Z, Reed AM, Ascherman DP, Levesque MC. Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab. Rheumatology (Oxford). 2016 Sep;55(9):1710.